Inhibition of pulmonary cancer progression by epidermal growth factor receptor-targeted transfection with Bcl-2 and survivin siRNAs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibition of pulmonary cancer progression by epidermal growth factor receptor-targeted transfection with Bcl-2 and survivin siRNAs

Published:2015-04-10 Issue:7 Volume:22 Page:335-343
ISSN:0929-1903
Container-title:Cancer Gene Therapy
language:en
Short-container-title:Cancer Gene Ther

Author:

Lee Y K,Lee T S,Song I H,Jeong H Y,Kang S J,Kim M W,Ryu S H,Jung I H,Kim J S,Park Y S

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/cgt201518.pdf

Reference34 articles.

1. Shuey DJ, McCallus DE, Giordano T . RNAi: gene-silencing in therapeutic intervention. Drug Discov Today 2002; 20: 1040–1046.

2. Uprichard SL . The therapeutic potential of RNA interference. FEBS Lett 2005; 579: 5996–6007.

3. Ozpolat B, Sood AK, Lopez-Berestein G . Nanomedicine based approaches for the delivery of siRNA in cancer. J Intern Med 2010; 267: 44–53.

4. Vicentini FT, Borgheti-Cardoso LN, Depieri LV, de Macedo Mano D, Abelha TF, Petrilli R et al. Delivery systems and local administration routes for therapeutic siRNA. Pharm Res 2013; 30: 915–931.

5. Akhtar S, Benter IF . Nonviral delivery of synthetic siRNAs in vivo. J Clin Invest 2007; 117: 3623–3632.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid-Based Nanocarriers for Targeted Gene Delivery in Lung Cancer Therapy: Exploring a Novel Therapeutic Paradigm;Current Gene Therapy;2025-04

2. An insight of various vesicular systems, erythrosomes, and exosomes to control metastasis and cancer;Advances in Cancer Biology - Metastasis;2023-07

3. MiR-126-Loaded Immunoliposomes against Vascular Endothelial Inflammation In Vitro and Vivo Evaluation;Pharmaceutics;2023-04-30

4. Multifunctional Liposomes to Attain Targeting, Stimuli Sensitive Drug Release and Imaging Cancer;Studies in Mechanobiology, Tissue Engineering and Biomaterials;2023

5. Safety Issues Related to Pluripotent Stem Cell-Based Therapies: Tumour Risk;Pluripotent Stem Cell Therapy for Diabetes;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3